Morning Glory Sciences
Morning Glory Sciences @MorningGlorySci ·
The future of CAR-T depends on systems that actually run. A practical look at commercialization, V2V, comparability, LTFU, and access. #CART #Immunotherapy #Biotech #CellTherapy morningglorysciences.com/en/frontier-of…
Frontier of Therapy Series: Training Immunity to Fight Cancer: The Full Picture of CAR-T (From...

In A5 and B5, we explored how in vivo CAR-T is emerging not simply as a novel scientific idea, but as a possible answer to the structural problems of

From morningglorysciences.com
1
The Pharma Letter
The Pharma Letter @ThePharmaLetter ·
The conflict in Iran is creating real risks for global pharma and biotech — API sourcing, clinical trial logistics, market access. The industry's exposure to Middle East instability is more significant than most realise. #pharma #biotech #supplychain #geopolitics thepharmaletter.com/pharma-news/th…
The war in Iran: risks to global pharma and biotech

Disruption in the Gulf has tightened oil flows through the Strait of Hormuz, a route that typically carries about a quarter of global seaborne crude. Before the Iran war, around 20 million barrels a...

From thepharmaletter.com
59
ORF हिन्दी
ORF हिन्दी @orfhindi ·
अब नई तकनीकें जैसे 3D सेल सिस्टम, ओमिक्स और आर्टिफिशियल इंटेलिजेंस वैज्ञानिकों को मानव शरीर और बीमारियों को बेहतर समझने में मदद कर रही हैं, इसलिए सरकारें नई मानव-आधारित तकनीकों को बढ़ावा दे रही हैं. #MedicalScience #BioTech #Innovation #HealthTech #Future orfonline.org/hindi/expert-s…
पशु परीक्षण खत्म? दवा जांच में मानव-युग!

दुनिया भर में नियम इसलिए बदल रहे हैं क्योंकि दवाओं की जांच के लिए लंबे समय से जानवरों का उपयोग होता रहा है लेकिन उनसे हमेशा इंसानों पर असर का सही पता नहीं चलता.

From orfonline.org
10
JoinCare Global
JoinCare Global @JoinCare_Server ·
People say biotech is slow. But what they really mean is they’re not seeing constant updates. Science doesn’t report progress the same way markets do. #JoinCare #Biotech #DeSci
2
743